The iCMLf is calling for applications to build and maintain a global registry of TFR cases, for the predominant purpose of improving our understanding regarding the determinants of TFR.

Expressions of interest are sought by February 10^th
and should be submitted to info@cml-foundation.org

Finding a cure for CML remains a long-term goal of the Foundation. In 2021 the iCMLf will not only continue to support the global CML community through the pandemic, but also shift our efforts back towards the iCMLf Cure Consortium once again.

As a first important step, we are allocating US$100,000 of iCMLf funds raised through the iCMLf Climb for a Cure and iCMLf Run.Ride.Cure to the iCMLf Treatment Free Remission (TFR) Alliance to establish a global registry of TFR cases, for the purpose of improving our understanding regarding the determinants of TFR.

Read more

In these challenging times of the COVID-19 pandemic, it is more important than ever to direct all our efforts to provide the best possible care for patients with CML around the globe and to continue to work towards a cure for CML.

With this in mind, we continue with our tradition to recognise and reward personal contributions and outstanding achievements to our understanding of the biology of CML and to improving the management of patients with CML globally.

Since the first iCMLf Rowley Prize was awarded to Professor Brian Druker in 2009, we have honoured 26 scientists and clinicians with the three specific iCMLf Prizes.

Who would you like to see awarded the iCMLf prizes next year?

Read more